HWHanbi Wang

Hanbi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hanbi Wang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Chengyan Deng

    Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing 100730, China.

    2 shared publications
  • Wanyu Zhang

    Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P. R. China

    2 shared publications
  • Bing Xing

    Department of Neurosurgery, Center for Pituitary Surgery, China Pituitary Disease Registry Center, China Pituitary Adenoma Specialist Council, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    1 shared publication
  • Cong Lu

    Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Reproductive Physiology Laboratory, National Research Institute for Family Planning, Beijing 100081, China

    1 shared publication
  • Duoxing Zhang

    Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    1 shared publication
  • Haihang Li

    College of Biomedical Engineering, Sichuan University, Sichuan Province 610065, China

    1 shared publication

Latest Publications

  • Open Access

    Effects of miR-210-3p/SDF2 and miR-31-5p/FGF7 from hypoxic endometrial exosomes on UCB-MSC proliferation, migration, and differentiation

    by Simiao Liu, Wanyu Zhang, Chengyan Deng, Hanbi Wang

    Mesenchymal stem cells (MSCs) isolated from umbilical cord blood (UCB) exhibit significant therapeutic efficacy in endometriosis; however, the molecular mechanisms governing their regulation remain incompletely elucidated. This study delves into the regulatory functions of miR-210-3p and miR-31-5p, which are secreted via exosomes from hypoxia-damaged endometrial epithelial cells, in modulating the behavior of UCB-MSCs. UCB-MSCs were transfected with specific inhibitors targeting miR-210-3p and miR-31-5p. Proliferation and migratory capacities were quantified using CCK8, EdU incorporation, Transwell, and scratch wound healing assays. Western blotting was employed to assess the expression of endometrial epithelial markers (CD9 and CK19) and stromal markers (Vimentin and CD13), alongside the phosphorylation status of JAK2 and STAT3. Dual-luciferase reporter assays were conducted to validate SDF2 and FGF7 as direct targets of miR-210-3p and miR-31-5p, respectively. Suppression of miR-210-3p and miR-31-5p significantly augmented the proliferative and migratory abilities of UCB-MSCs, while simultaneously enhancing their differentiation into endometrial epithelial cells and attenuating their transition into stromal cells. Concurrently, the phosphorylation levels of JAK2 and STAT3 were markedly elevated. Overexpression of SDF2 and FGF7 further amplified the proliferative, migratory, and epithelial differentiation capacities of UCB-MSCs, accompanied by heightened activation of the JAK2/STAT3 signaling pathway. Notably, SDF2 overexpression and FGF7 overexpression effectively counteracted the inhibitory effects exerted by miR-210-3p and miR-31-5p mimics on UCB-MSC proliferation, migration, and epithelial differentiation, mediated through the modulation of JAK2/STAT3 signaling. miR-210-3p and miR-31-5p orchestrate the functional dynamics of UCB-MSCs by targeting SDF2 and FGF7, respectively, through the JAK2/STAT3 pathway. These findings unveil novel mechanistic insights into the regenerative potential of UCB-MSCs, offering promising avenues for therapeutic advancements in endometriosis. NOTE: Schematic diagram illustrates how miR-210-3p and miR-31-5p regulate the biological processes of proliferation, migration, and differentiation in umbilical cord blood mesenchymal stem cells (UCB-MSCs) by targeting SDF2 and FGF7, respectively, through JAK2/STAT3 pathway.


  • Open Access

    Preoperative and postoperative blood testosterone levels in patients with acromegaly: a prospective study

    by Duoxing Zhang, Xiaopeng Guo, Ming Feng, Xinjie Bao, Kan Deng, Yong Yao, Wei Lian, Bing Xing, Hanbi Wang

    Purpose: To investigate the prevalence of low blood testosterone level (LTL) and its determinant factors among active male acromegaly patients, as well as the effect of surgery on LTL in male acromegaly patients.Methods: A retrospective, single-center study focused on 252 male acromegaly patients aged 18 years–60 years diagnosed in the Peking Union Medical College Hospital from January 2015 to December 2018 was carried out. The measurements of preoperative and postoperative testosterone levels, serum growth hormone (GH), insulin-like growth factor 1 (IGF-1), and other clinical data were analyzed.Results: Forty per cent of subjects included were diagnosed with LTL pre surgery. Patients were divided into normal testosterone level (NTL) and LTL groups based on their testosterone level. There were significant differences (p < 0.01) between groups in the presence of macroadenomas, invasion of the cavernous sinus, compression of the optic chiasm, and serum GH and prolactin levels pre surgery. Invasion of the cavernous sinus [odds ratio (OR) = 4.299; p = 0.000] and serum prolactin level (OR = 1.023, p = 0.001) were independent predictors of LTLs in male patients before surgical intervention. A total of 67.9% of LTL patients recovered during the follow-up, with a new-onset rate of 3.4%. Body mass index, invasion of the cavernous sinus, GH, IGF-1, and prolactin levels, the presence of a prolactin-secreting tumor, and recovery from acromegaly were significantly different (p < 0.05) in the NTL group and in the LTL group during the follow-up. The presence of a prolactin-secreting tumor (OR = 0.224; p = 0.001) and recovery from acromegaly (OR = 0.168; p = 0.006) were independent predictors of LTLs in male acromegaly patients during the follow-up.Conclusion: The invasiveness of tumor and levels of blood prolactin are independent factors for LTLs before surgery, whereas GH and IGF-1 levels are not. Most male patients can recover from LTL after tumor restriction surgery: those who recover from acromegaly have a better chance of recovering from LTL.


  • Injectable self-assembled dual-crosslinked alginate/recombinant collagen-based hydrogel for endometrium regeneration

    by Ziyuan Fang, Cong Lu, Wenjun Du, Xue Wang, Huiyi Yang, Miaojie Shi, Tingting Liu, Yajie Xie, Shufang Wang, Xiangbo Xu, et al.


  • Retracted
    Open Access

    [Retracted] Human Umbilical Cord Mesenchymal Stem Cell‐Derived Exosome Repairs Endometrial Epithelial Cells Injury Induced by Hypoxia via Regulating miR‐663a/CDKN2A Axis

    by Hanbi Wang, Simiao Liu, Wanyu Zhang, Meizhi Liu, Chengyan Deng

    Aim. Thin endometrium remains a severe clinical challenge with no effective therapy to date. We aimed at exploring the role and molecular mechanism of human umbilical cord mesenchymal stem cell‐ (hucMSC‐) derived exosomes (hucMSC‐Ex) in repairing hypoxic injury of endometrial epithelial cells (EECs). Methods. Exosomes were harvested from the conditioned medium of hucMSC and characterized using western blot, transmission electron microscopy (TEM), flow cytometry, and nanoparticle tracking analysis (NTA). EECs were subjected to hypoxic conditions before cocultured with hucMSC‐Ex. Cell viability, apoptosis, and migration were determined with CCK‐8, flow cytometry, and wound healing assay, respectively. Apoptosis/EMT‐related proteins were detected by western blot. The miRNA profiling was determined by RNA sequencing. The expression of miR‐663a and CDKN2A was measured by qRT‐PCR. MiR‐663a in EECs was overexpressed by transfecting with miR‐663a mimics. Results. Mesenchymal stem cells (MSCs) markers CD73, CD90, and CD106 were positively expressed in hucMSCs. Exosome isolated from hucMSC expressed CD63 and TSG101, and were 100–150 nm in diameter. HucMSC‐Ex promoted cell proliferation inhibited by hypoxia. And hucMSC‐Ex also inhibited hypoxia‐induced apoptosis, migration, and EMT of EECs by upregulating the expression of Bcl‐2 and E‐cadherin and downregulating Bax and N‐cadherin levels. Further, bioinformatics research found that hucMSC‐Ex coculture can significantly upregulate the expression of miR‐663a and decrease the expression of CDKN2A in hypoxia‐induced EECs. Furthermore, miR‐663a overexpression inhibited CDKN2A expression and increased the expression of Bcl‐2 and E‐cadherin in hypoxia‐induced EECs. Conclusions. HucMSC‐Ex promoted cell proliferation, inhibited cell apoptosis, migration, and EMT in hypoxia‐induced EECs, thereby alleviating hypoxia‐induced EECs injury, which may be related to its regulation of miR‐663a/CDKN2A expression. Our study indicated that hucMSC‐Ex might benefit for repairing thin endometrium.